Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1

Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation. Ewing's sarcoma primarily occurs in the bone and soft tissues. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of ge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:In vitro cellular & developmental biology. Animal 2018-12, Vol.54 (10), p.770-778
Hauptverfasser: Oyama, Rieko, Kito, Fusako, Qiao, Zhiwei, Sakumoto, Marimu, Noguchi, Rei, Takahashi, Mami, Toki, Shunichi, Tanzawa, Yoshikazu, Yoshida, Akihiko, Kawai, Akira, Kondo, Tadashi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 778
container_issue 10
container_start_page 770
container_title In vitro cellular & developmental biology. Animal
container_volume 54
creator Oyama, Rieko
Kito, Fusako
Qiao, Zhiwei
Sakumoto, Marimu
Noguchi, Rei
Takahashi, Mami
Toki, Shunichi
Tanzawa, Yoshikazu
Yoshida, Akihiko
Kawai, Akira
Kondo, Tadashi
description Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation. Ewing's sarcoma primarily occurs in the bone and soft tissues. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of genetic alterations in relevant cellular contexts. Here, we report the establishment and characterization of a novel Ewing's sarcoma cell line following primary Ewing's sarcoma tumor tissue culture. The established cell line was authenticated by DNA microsatellite short tandem repeat analysis, characterized by in vitro assays, and named NCC-ES1-C1. The NCC-ES1-C1 cell line grew well for 15 mo and was subcultured more than 50 times during this period. Characterization of the cells revealed that they were not adherent and showed floating features. In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-C1, from primary tumor tissue. The cell line has the characteristic EWSR1-FLI1 gene fusion and exhibits aggressive growth in vitro. Thus, the NCC-ES1-C1 cell line will be a useful tool for investigating the mechanisms of disease and the biological role of the EWSR1-FLI1 fusion gene.
doi_str_mv 10.1007/s11626-018-0302-2
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_journals_2207813541</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>45179013</jstor_id><sourcerecordid>45179013</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-47797da8b30d9639d7bce9f23769e135ec452480ccb43bfbf72b8c5f8c0cf15a3</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMo3h_AjQRE3Bg9J0mbdillvICMCxXchTRNtUOnHZOO4tubod5WZpNw8l8OHyEHCGcIoM4DYspTBpgxEMAZXyPbmEjBFKRP6_ENChlPc9giOyHMIJ4c002yJUBwyaXcJtNJGEzZNuFl7rqB9jU1tOvfXEsXZmjiiFXON2-uopP3pns-CTQYb_u5oda1LW2bzp3SaVGwyT2yAvfIRm3a4Pa_7l3yeDl5KK7Z7d3VTXFxy6xMs4FJpXJVmawUUOWpyCtVWpfXXKg0dygSZ2XCZQbWllKUdVkrXmY2qTMLtsbEiF1yNOYufP-6dGHQs37pu1ipOQeVxQyJUYWjyvo-BO9qvfDN3PgPjaBXBPVIUEeCekVQ8-g5_EpelnNX_Ti-kUUBHwUhfnXPzv9W_5d6PJpmYej93zW4iAaZoMoBhfgErjqEzQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2207813541</pqid></control><display><type>article</type><title>Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>Springer Nature - Complete Springer Journals</source><creator>Oyama, Rieko ; Kito, Fusako ; Qiao, Zhiwei ; Sakumoto, Marimu ; Noguchi, Rei ; Takahashi, Mami ; Toki, Shunichi ; Tanzawa, Yoshikazu ; Yoshida, Akihiko ; Kawai, Akira ; Kondo, Tadashi</creator><creatorcontrib>Oyama, Rieko ; Kito, Fusako ; Qiao, Zhiwei ; Sakumoto, Marimu ; Noguchi, Rei ; Takahashi, Mami ; Toki, Shunichi ; Tanzawa, Yoshikazu ; Yoshida, Akihiko ; Kawai, Akira ; Kondo, Tadashi</creatorcontrib><description>Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation. Ewing's sarcoma primarily occurs in the bone and soft tissues. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of genetic alterations in relevant cellular contexts. Here, we report the establishment and characterization of a novel Ewing's sarcoma cell line following primary Ewing's sarcoma tumor tissue culture. The established cell line was authenticated by DNA microsatellite short tandem repeat analysis, characterized by in vitro assays, and named NCC-ES1-C1. The NCC-ES1-C1 cell line grew well for 15 mo and was subcultured more than 50 times during this period. Characterization of the cells revealed that they were not adherent and showed floating features. In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-C1, from primary tumor tissue. The cell line has the characteristic EWSR1-FLI1 gene fusion and exhibits aggressive growth in vitro. Thus, the NCC-ES1-C1 cell line will be a useful tool for investigating the mechanisms of disease and the biological role of the EWSR1-FLI1 fusion gene.</description><identifier>ISSN: 1071-2690</identifier><identifier>EISSN: 1543-706X</identifier><identifier>DOI: 10.1007/s11626-018-0302-2</identifier><identifier>PMID: 30324244</identifier><language>eng</language><publisher>New York: Springer Science &amp; Business Media LLC</publisher><subject>Adult ; Animal Genetics and Genomics ; Animals ; Antineoplastic Agents - pharmacology ; Base Sequence ; Biomedical and Life Sciences ; Cancer therapies ; Cell Biology ; Cell Culture ; Cell Line, Tumor ; Chemotherapy ; Children &amp; youth ; Deoxyribonucleic acid ; Developmental Biology ; DNA ; Drug Evaluation, Preclinical ; Drugs ; ESTABLISHMENT OF CELL LINES ; Ewing's sarcoma ; Ewings sarcoma ; Female ; FLI-1 protein ; FLI1 protein ; Fusion protein ; Gene Dosage ; Gene expression ; Gene Expression Regulation, Neoplastic - drug effects ; Genetic testing ; Humans ; Kinases ; Life Sciences ; Male ; Medical prognosis ; Mesenchyme ; Metastasis ; Mice, Inbred NOD ; Microsatellite Repeats - genetics ; Oncogene Proteins, Fusion - genetics ; Oncogene Proteins, Fusion - metabolism ; Patients ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Sarcoma ; Sarcoma, Ewing - diagnostic imaging ; Sarcoma, Ewing - genetics ; Sarcoma, Ewing - pathology ; Soft tissues ; Stem Cells ; Tissue culture ; Tissues ; Translocation ; Tumors ; Xenograft Model Antitumor Assays</subject><ispartof>In vitro cellular &amp; developmental biology. Animal, 2018-12, Vol.54 (10), p.770-778</ispartof><rights>2018 Society for In Vitro Biology</rights><rights>The Society for In Vitro Biology 2018</rights><rights>Copyright Society for In Vitro Biology Dec 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-47797da8b30d9639d7bce9f23769e135ec452480ccb43bfbf72b8c5f8c0cf15a3</citedby><cites>FETCH-LOGICAL-c468t-47797da8b30d9639d7bce9f23769e135ec452480ccb43bfbf72b8c5f8c0cf15a3</cites><orcidid>0000-0001-6405-7792</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/45179013$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/45179013$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,777,781,800,27905,27906,41469,42538,51300,57998,58231</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30324244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oyama, Rieko</creatorcontrib><creatorcontrib>Kito, Fusako</creatorcontrib><creatorcontrib>Qiao, Zhiwei</creatorcontrib><creatorcontrib>Sakumoto, Marimu</creatorcontrib><creatorcontrib>Noguchi, Rei</creatorcontrib><creatorcontrib>Takahashi, Mami</creatorcontrib><creatorcontrib>Toki, Shunichi</creatorcontrib><creatorcontrib>Tanzawa, Yoshikazu</creatorcontrib><creatorcontrib>Yoshida, Akihiko</creatorcontrib><creatorcontrib>Kawai, Akira</creatorcontrib><creatorcontrib>Kondo, Tadashi</creatorcontrib><title>Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1</title><title>In vitro cellular &amp; developmental biology. Animal</title><addtitle>In Vitro Cell.Dev.Biol.-Animal</addtitle><addtitle>In Vitro Cell Dev Biol Anim</addtitle><description>Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation. Ewing's sarcoma primarily occurs in the bone and soft tissues. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of genetic alterations in relevant cellular contexts. Here, we report the establishment and characterization of a novel Ewing's sarcoma cell line following primary Ewing's sarcoma tumor tissue culture. The established cell line was authenticated by DNA microsatellite short tandem repeat analysis, characterized by in vitro assays, and named NCC-ES1-C1. The NCC-ES1-C1 cell line grew well for 15 mo and was subcultured more than 50 times during this period. Characterization of the cells revealed that they were not adherent and showed floating features. In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-C1, from primary tumor tissue. The cell line has the characteristic EWSR1-FLI1 gene fusion and exhibits aggressive growth in vitro. Thus, the NCC-ES1-C1 cell line will be a useful tool for investigating the mechanisms of disease and the biological role of the EWSR1-FLI1 fusion gene.</description><subject>Adult</subject><subject>Animal Genetics and Genomics</subject><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Base Sequence</subject><subject>Biomedical and Life Sciences</subject><subject>Cancer therapies</subject><subject>Cell Biology</subject><subject>Cell Culture</subject><subject>Cell Line, Tumor</subject><subject>Chemotherapy</subject><subject>Children &amp; youth</subject><subject>Deoxyribonucleic acid</subject><subject>Developmental Biology</subject><subject>DNA</subject><subject>Drug Evaluation, Preclinical</subject><subject>Drugs</subject><subject>ESTABLISHMENT OF CELL LINES</subject><subject>Ewing's sarcoma</subject><subject>Ewings sarcoma</subject><subject>Female</subject><subject>FLI-1 protein</subject><subject>FLI1 protein</subject><subject>Fusion protein</subject><subject>Gene Dosage</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Genetic testing</subject><subject>Humans</subject><subject>Kinases</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Mesenchyme</subject><subject>Metastasis</subject><subject>Mice, Inbred NOD</subject><subject>Microsatellite Repeats - genetics</subject><subject>Oncogene Proteins, Fusion - genetics</subject><subject>Oncogene Proteins, Fusion - metabolism</subject><subject>Patients</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Sarcoma</subject><subject>Sarcoma, Ewing - diagnostic imaging</subject><subject>Sarcoma, Ewing - genetics</subject><subject>Sarcoma, Ewing - pathology</subject><subject>Soft tissues</subject><subject>Stem Cells</subject><subject>Tissue culture</subject><subject>Tissues</subject><subject>Translocation</subject><subject>Tumors</subject><subject>Xenograft Model Antitumor Assays</subject><issn>1071-2690</issn><issn>1543-706X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kMtKxDAUhoMo3h_AjQRE3Bg9J0mbdillvICMCxXchTRNtUOnHZOO4tubod5WZpNw8l8OHyEHCGcIoM4DYspTBpgxEMAZXyPbmEjBFKRP6_ENChlPc9giOyHMIJ4c002yJUBwyaXcJtNJGEzZNuFl7rqB9jU1tOvfXEsXZmjiiFXON2-uopP3pns-CTQYb_u5oda1LW2bzp3SaVGwyT2yAvfIRm3a4Pa_7l3yeDl5KK7Z7d3VTXFxy6xMs4FJpXJVmawUUOWpyCtVWpfXXKg0dygSZ2XCZQbWllKUdVkrXmY2qTMLtsbEiF1yNOYufP-6dGHQs37pu1ipOQeVxQyJUYWjyvo-BO9qvfDN3PgPjaBXBPVIUEeCekVQ8-g5_EpelnNX_Ti-kUUBHwUhfnXPzv9W_5d6PJpmYej93zW4iAaZoMoBhfgErjqEzQ</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Oyama, Rieko</creator><creator>Kito, Fusako</creator><creator>Qiao, Zhiwei</creator><creator>Sakumoto, Marimu</creator><creator>Noguchi, Rei</creator><creator>Takahashi, Mami</creator><creator>Toki, Shunichi</creator><creator>Tanzawa, Yoshikazu</creator><creator>Yoshida, Akihiko</creator><creator>Kawai, Akira</creator><creator>Kondo, Tadashi</creator><general>Springer Science &amp; Business Media LLC</general><general>Springer US</general><general>Society for In Vitro Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7QL</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><orcidid>https://orcid.org/0000-0001-6405-7792</orcidid></search><sort><creationdate>20181201</creationdate><title>Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1</title><author>Oyama, Rieko ; Kito, Fusako ; Qiao, Zhiwei ; Sakumoto, Marimu ; Noguchi, Rei ; Takahashi, Mami ; Toki, Shunichi ; Tanzawa, Yoshikazu ; Yoshida, Akihiko ; Kawai, Akira ; Kondo, Tadashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-47797da8b30d9639d7bce9f23769e135ec452480ccb43bfbf72b8c5f8c0cf15a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Animal Genetics and Genomics</topic><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Base Sequence</topic><topic>Biomedical and Life Sciences</topic><topic>Cancer therapies</topic><topic>Cell Biology</topic><topic>Cell Culture</topic><topic>Cell Line, Tumor</topic><topic>Chemotherapy</topic><topic>Children &amp; youth</topic><topic>Deoxyribonucleic acid</topic><topic>Developmental Biology</topic><topic>DNA</topic><topic>Drug Evaluation, Preclinical</topic><topic>Drugs</topic><topic>ESTABLISHMENT OF CELL LINES</topic><topic>Ewing's sarcoma</topic><topic>Ewings sarcoma</topic><topic>Female</topic><topic>FLI-1 protein</topic><topic>FLI1 protein</topic><topic>Fusion protein</topic><topic>Gene Dosage</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Genetic testing</topic><topic>Humans</topic><topic>Kinases</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Mesenchyme</topic><topic>Metastasis</topic><topic>Mice, Inbred NOD</topic><topic>Microsatellite Repeats - genetics</topic><topic>Oncogene Proteins, Fusion - genetics</topic><topic>Oncogene Proteins, Fusion - metabolism</topic><topic>Patients</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Sarcoma</topic><topic>Sarcoma, Ewing - diagnostic imaging</topic><topic>Sarcoma, Ewing - genetics</topic><topic>Sarcoma, Ewing - pathology</topic><topic>Soft tissues</topic><topic>Stem Cells</topic><topic>Tissue culture</topic><topic>Tissues</topic><topic>Translocation</topic><topic>Tumors</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oyama, Rieko</creatorcontrib><creatorcontrib>Kito, Fusako</creatorcontrib><creatorcontrib>Qiao, Zhiwei</creatorcontrib><creatorcontrib>Sakumoto, Marimu</creatorcontrib><creatorcontrib>Noguchi, Rei</creatorcontrib><creatorcontrib>Takahashi, Mami</creatorcontrib><creatorcontrib>Toki, Shunichi</creatorcontrib><creatorcontrib>Tanzawa, Yoshikazu</creatorcontrib><creatorcontrib>Yoshida, Akihiko</creatorcontrib><creatorcontrib>Kawai, Akira</creatorcontrib><creatorcontrib>Kondo, Tadashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>In vitro cellular &amp; developmental biology. Animal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oyama, Rieko</au><au>Kito, Fusako</au><au>Qiao, Zhiwei</au><au>Sakumoto, Marimu</au><au>Noguchi, Rei</au><au>Takahashi, Mami</au><au>Toki, Shunichi</au><au>Tanzawa, Yoshikazu</au><au>Yoshida, Akihiko</au><au>Kawai, Akira</au><au>Kondo, Tadashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1</atitle><jtitle>In vitro cellular &amp; developmental biology. Animal</jtitle><stitle>In Vitro Cell.Dev.Biol.-Animal</stitle><addtitle>In Vitro Cell Dev Biol Anim</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>54</volume><issue>10</issue><spage>770</spage><epage>778</epage><pages>770-778</pages><issn>1071-2690</issn><eissn>1543-706X</eissn><abstract>Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation. Ewing's sarcoma primarily occurs in the bone and soft tissues. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of genetic alterations in relevant cellular contexts. Here, we report the establishment and characterization of a novel Ewing's sarcoma cell line following primary Ewing's sarcoma tumor tissue culture. The established cell line was authenticated by DNA microsatellite short tandem repeat analysis, characterized by in vitro assays, and named NCC-ES1-C1. The NCC-ES1-C1 cell line grew well for 15 mo and was subcultured more than 50 times during this period. Characterization of the cells revealed that they were not adherent and showed floating features. In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-C1, from primary tumor tissue. The cell line has the characteristic EWSR1-FLI1 gene fusion and exhibits aggressive growth in vitro. Thus, the NCC-ES1-C1 cell line will be a useful tool for investigating the mechanisms of disease and the biological role of the EWSR1-FLI1 fusion gene.</abstract><cop>New York</cop><pub>Springer Science &amp; Business Media LLC</pub><pmid>30324244</pmid><doi>10.1007/s11626-018-0302-2</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6405-7792</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1071-2690
ispartof In vitro cellular & developmental biology. Animal, 2018-12, Vol.54 (10), p.770-778
issn 1071-2690
1543-706X
language eng
recordid cdi_proquest_journals_2207813541
source MEDLINE; Jstor Complete Legacy; Springer Nature - Complete Springer Journals
subjects Adult
Animal Genetics and Genomics
Animals
Antineoplastic Agents - pharmacology
Base Sequence
Biomedical and Life Sciences
Cancer therapies
Cell Biology
Cell Culture
Cell Line, Tumor
Chemotherapy
Children & youth
Deoxyribonucleic acid
Developmental Biology
DNA
Drug Evaluation, Preclinical
Drugs
ESTABLISHMENT OF CELL LINES
Ewing's sarcoma
Ewings sarcoma
Female
FLI-1 protein
FLI1 protein
Fusion protein
Gene Dosage
Gene expression
Gene Expression Regulation, Neoplastic - drug effects
Genetic testing
Humans
Kinases
Life Sciences
Male
Medical prognosis
Mesenchyme
Metastasis
Mice, Inbred NOD
Microsatellite Repeats - genetics
Oncogene Proteins, Fusion - genetics
Oncogene Proteins, Fusion - metabolism
Patients
RNA, Messenger - genetics
RNA, Messenger - metabolism
Sarcoma
Sarcoma, Ewing - diagnostic imaging
Sarcoma, Ewing - genetics
Sarcoma, Ewing - pathology
Soft tissues
Stem Cells
Tissue culture
Tissues
Translocation
Tumors
Xenograft Model Antitumor Assays
title Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A34%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Establishment%20of%20a%20novel%20patient-derived%20Ewing's%20sarcoma%20cell%20line,%20NCC-ES1-C1&rft.jtitle=In%20vitro%20cellular%20&%20developmental%20biology.%20Animal&rft.au=Oyama,%20Rieko&rft.date=2018-12-01&rft.volume=54&rft.issue=10&rft.spage=770&rft.epage=778&rft.pages=770-778&rft.issn=1071-2690&rft.eissn=1543-706X&rft_id=info:doi/10.1007/s11626-018-0302-2&rft_dat=%3Cjstor_proqu%3E45179013%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2207813541&rft_id=info:pmid/30324244&rft_jstor_id=45179013&rfr_iscdi=true